HALD1
MCID: ALD010
MIFTS: 49

Aldosteronism, Glucocorticoid-Remediable (HALD1) malady

Categories: Genetic diseases, Rare diseases, Cardiovascular diseases, Nephrological diseases, Endocrine diseases

Aliases & Classifications for Aldosteronism, Glucocorticoid-Remediable

About this section

Aliases & Descriptions for Aldosteronism, Glucocorticoid-Remediable:

Name: Aldosteronism, Glucocorticoid-Remediable 52 12
Glucocorticoid-Remediable Aldosteronism 52 11 48 24 54 70 50 39 13 68
Familial Hyperaldosteronism Type 1 48 24 54 68
Glucocorticoid-Suppressible Hyperaldosteronism 24 70
Glucocorticoid Sensitive Hypertension 48 70
Dexamethasone Sensitive Hypertension 48 70
Familial Hyperaldosteronism Type I 54 70
Familial Hyperaldosteronism 1 70 27
Fh1 54 70
Gra 54 70
Acth-Dependent Hyperaldosteronism Syndrome 70
Aldosteronism, Sensitive to Dexamethasone 24
 
Aldosteronism Sensitive to Dexamethasone 70
Glucocorticoid-Sensitive Hypertension 54
Dexamethasone-Sensitive Hypertension 54
Hyperaldosteronism, Familial Type 1 48
Hyperaldosteronism, Familial, 1 70
Familial Aldosteronism Type I 68
Fh Type 1 70
Hald1 70
Fh I 70
Fh-I 54
Gsh 70

Characteristics:

Orphanet epidemiological data:

54
glucocorticoid-remediable aldosteronism:
Inheritance: Autosomal dominant; Age of onset: Adolescent,Adult,Childhood; Age of death: normal life expectancy

HPO:

64
aldosteronism, glucocorticoid-remediable:
Inheritance: autosomal dominant inheritance
Onset and clinical course: onset

Classifications:



External Ids:

OMIM52 103900
Disease Ontology11 DOID:14080
ICD1030 E26.02
ICD9CM32 255.11
SNOMED-CT62 237743003
NCIt45 C123248
Orphanet54 ORPHA403
ICD10 via Orphanet31 E26.0
MedGen37 C1260386

Summaries for Aldosteronism, Glucocorticoid-Remediable

About this section
NIH Rare Diseases:48 Glucocorticoid-remediable aldosteronism is one of three types of familial hyperaldosteronism. aldosterone is a hormone manufactured by the adrenal glands which helps the body retain water and sodium and excrete potassium. it is caused by a fusion of the cyp11b1 and cyp11b2 genes and is inherited in an autosomal dominant manner. individuals with this condition usually have hypertension (high blood pressure) before age 21. these individuals are also at an increased risk for a certain type of stroke known as a hemorrhagic stroke. first-line therapy consists of a steroid such as prednisone, dexamethasone, or hydrocortisone. this will often correct the overproduction of aldosterone, lower the blood pressure, and correct the potassium levels. last updated: 6/12/2015

MalaCards based summary: Aldosteronism, Glucocorticoid-Remediable, also known as glucocorticoid-remediable aldosteronism, is related to hyperaldosteronism, familial, type iii and spastic ataxia 3, and has symptoms including Array, Array and Array. An important gene associated with Aldosteronism, Glucocorticoid-Remediable is CYP11B1 (Cytochrome P450 Family 11 Subfamily B Member 1), and among its related pathways are superpathway of steroid hormone biosynthesis and Renin secretion. Affiliated tissues include adrenal gland, and related mouse phenotypes are Increased transferrin (TF) endocytosis and adipose tissue.

OMIM:52 Glucocorticoid-remediable aldosteronism is an autosomal dominant disorder characterized by hypertension, variable... (103900) more...

UniProtKB/Swiss-Prot:70 Hyperaldosteronism, familial, 1: A disorder characterized by hypertension, variable hyperaldosteronism, and abnormal adrenal steroid production, including 18-oxocortisol and 18-hydroxycortisol. There is significant phenotypic heterogeneity, and some individuals never develop hypertension.

Wikipedia:71 Glucocorticoid remediable aldosteronism (GRA), also describable as aldosterone synthase hyperactivity,... more...

Related Diseases for Aldosteronism, Glucocorticoid-Remediable

About this section

Diseases related to Aldosteronism, Glucocorticoid-Remediable via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 101)
idRelated DiseaseScoreTop Affiliating Genes
1hyperaldosteronism, familial, type iii32.1NR3C2, REN
2spastic ataxia 310.2CYP11B1, CYP11B2
3intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies10.2CYP11B1, CYP11B2
4cardiomyopathy, dilated, 1v10.2CYP11B1, CYP11B2
5smith-mccort dysplasia 210.2NR3C2, REN
6dystonia 2510.2NR3C2, REN
7distal monosomy 14q10.2POMC, REN
8microphthalmia, syndromic 910.2CYP11B1, POMC
9glossopharyngeal nerve neoplasm10.2POMC, REN
10endometrial mixed adenocarcinoma10.2POMC, REN
11iris disease10.1AGT, REN
12cascade stomach10.1AGT, REN
13hyperuricemic nephropathy, familial juvenile 210.1AGT, REN
14aplasia cutis congenita recessive10.1AGT, CYP11B2
15ameloblastoma10.1CYP11B1, POMC
16malignant otitis externa10.1POMC, REN
17familial multiple trichodiscomas10.1POMC, REN
18lymphoproliferative syndrome 210.1NR3C2, REN
19eastern equine encephalitis10.1AGT, REN
20flat umbilicus familial10.1AGT, REN
21astroblastoma10.1POMC, REN
22clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly10.1NR3C1, NR3C2
23episodic kinesigenic dyskinesia 210.1AGT, REN
24hyperaldosteronism10.1
25familial hyperaldosteronism10.1
26retinitis pigmentosa10.1NR3C2, REN
27schizotypal personality disorder10.1AGT, REN
28nonparalytic poliomyelitis10.1NR3C1, POMC
29jackson-weiss syndrome10.0CYP11B1, CYP11B2, POMC
30benign peritoneal mesothelioma10.0CYP11B1, CYP11B2, POMC
31microphthalmia, isolated, with coloboma 710.0CYP11B2, NR3C2, REN
32second-degree atrioventricular block10.0CYP11B1, CYP11B2, POMC
33critical limb ischemia10.0CYP11B2, NR3C2, REN
34loeffler endocarditis10.0CYP11B1, POMC, REN
35hypogonadism mitral valve prolapse mental retardation10.0CYP11B2, POMC, REN
36indian tick typhus10.0POMC, REN
37endotheliitis10.0
38vestibular gland benign neoplasm10.0CYP11B2, POMC, REN
39laryngostenosis10.0AGT, CYP11B2, NR3C2
40infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations10.0NR3C1, POMC
41deafness, autosomal recessive 7910.0POMC, REN
42hypermobility syndrome10.0POMC, REN
43peeling skin syndrome10.0NR3C1, POMC
44fatty liver disease10.0POMC, REN
45traumatic glaucoma9.9HSD11B2, POMC
46glioma susceptibility 19.9CYP11B1, CYP11B2, HSD11B2
47neuroblastoma9.9
48apparent mineralocorticoid excess9.9
49intracranial aneurysm9.9
50adenoma9.9

Graphical network of the top 20 diseases related to Aldosteronism, Glucocorticoid-Remediable:



Diseases related to aldosteronism, glucocorticoid-remediable

Symptoms & Phenotypes for Aldosteronism, Glucocorticoid-Remediable

About this section

Symptoms by clinical synopsis from OMIM:

103900

Clinical features from OMIM:

103900

Human phenotypes related to Aldosteronism, Glucocorticoid-Remediable:

 54 64 (show all 19)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hypertension64 54 Obligate (100%) HP:0000822
2 dexamethasone-suppresible primary hyperaldosteronism64 54 Obligate (100%) HP:0011739
3 adrenal hyperplasia64 54 Very frequent (99-80%) HP:0008221
4 abnormal circulating renin64 54 Very frequent (99-80%) HP:0040084
5 tinnitus64 54 Occasional (29-5%) HP:0000360
6 epistaxis64 54 Occasional (29-5%) HP:0000421
7 muscle weakness64 54 Occasional (29-5%) HP:0001324
8 polydipsia64 54 Occasional (29-5%) HP:0001959
9 nausea64 54 Occasional (29-5%) HP:0002018
10 intracranial hemorrhage64 54 Occasional (29-5%) HP:0002170
11 headache64 54 Occasional (29-5%) HP:0002315
12 hypokalemia64 54 Occasional (29-5%) HP:0002900
13 caesarian section64 54 Occasional (29-5%) HP:0011410
14 secretory adrenocortical adenoma64 54 Occasional (29-5%) HP:0011746
15 preeclampsia64 54 Occasional (29-5%) HP:0100602
16 abnormality of the urinary system64 HP:0000079
17 adrenogenital syndrome64 HP:0000840
18 hyperaldosteronism64 HP:0000859
19 decreased circulating renin level64 HP:0003351

GenomeRNAi Phenotypes related to Aldosteronism, Glucocorticoid-Remediable according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00363-A8.1AGT, CYP11B1, CYP11B2, NR3C1, NR3C2, POMC

MGI Mouse Phenotypes related to Aldosteronism, Glucocorticoid-Remediable according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053759.3AGT, CYP11B2, NR3C1, POMC
2MP:00036318.3AGT, CYP11B2, NR3C1, NR3C2, POMC, REN
3MP:00053698.1AGT, CYP11B1, HSD11B2, NR3C1, NR3C2, REN
4MP:00053788.1AGT, CYP11B1, CYP11B2, NR3C1, NR3C2, POMC
5MP:00053867.6AGT, CYP11B1, HSD11B2, NR3C1, NR3C2, POMC
6MP:00107687.6AGT, CYP11B1, HSD11B2, NR3C1, NR3C2, POMC
7MP:00053857.3AGT, CYP11B1, CYP11B2, HSD11B2, NR3C1, NR3C2
8MP:00053767.2AGT, CYP11B1, CYP11B2, HSD11B2, NR3C1, NR3C2
9MP:00053676.4AGT, CYP11B1, CYP11B2, HSD11B2, NR3C1, NR3C2

Drugs & Therapeutics for Aldosteronism, Glucocorticoid-Remediable

About this section

Drugs for Aldosteronism, Glucocorticoid-Remediable (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 10)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SimvastatinapprovedPhase 351979902-63-954454
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
79902-63-9
AC-1530
AC1L1H1F
AKOS005111006
ARONIS24119
BCBcMAP01_000007
BIDD:GT0769
BPBio1_001001
BRD-K22134346-001-05-8
BRN 4768037
BSPBio_000909
BSPBio_002337
Bio-0672
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
C25H38O5
CCRIS 7558
CHEBI:9150
CHEMBL1064
CID54454
CPD000718785
Cholestat
Coledis
Colemin
Corolin
D00434
D019821
DRG-0320
Denan
DivK1c_006991
Eucor
HMS1570N11
HMS1922H13
HMS2089D12
HMS2093E06
HSDB 7208
InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
KBio1_001935
KBio2_002197
KBio2_004765
KBio2_007333
KBio3_001557
KBioGR_001244
KBioSS_002197
KS-1113
Kolestevan
L 644128-000U
LS-46264
Labistatin
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
MK 0733
MK 733
MK-0733
MK-733
MK733
MLS001304029
MLS001333077
MLS001333078
 
MLS002154038
Medipo
Modutrol
MolPort-002-507-345
MolPort-002-885-862
NCGC00017324-01
NCGC00017324-02
NCGC00017324-03
Nivelipol
Nor-Vastina
Pantok
Pepstatin
Prestwick0_000865
Prestwick1_000865
Prestwick2_000865
Prestwick3_000865
Prestwick_171
Rechol
Rendapid
S1792_Selleck
S6196_SIGMA
SAM002589969
SMR000718785
SPBio_001881
SPBio_002830
SPECTRUM1504236
STK801938
Simcor
Simovil
Simvast CR
Simvastatin
Simvastatin & Primycin
Simvastatin (JAN/USP/INN)
Simvastatin [USAN:INN:BAN]
Simvastatin [Usan:Ban:Inn]
Simvastatin lactone
Simvastatin, Compactin
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
Sivastin
SpecPlus_000895
Spectrum2_001671
Spectrum3_000669
Spectrum4_000632
Spectrum5_001428
Spectrum_001717
Statin
Synvinolin
TNP00259
UNII-AGG2FN16EV
Valemia
Vasotenal
Velostatin
Vytorin
ZINC03780893
Zocor
Zocor (TN)
Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin
Zocord
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta
nchembio790-comp16
simvastatin
2Pharmaceutical SolutionsPhase 38192
3Rosuvastatin CalciumPhase 3476147098-20-2
4AntibodiesPhase 36394
5ImmunoglobulinsPhase 36394
6Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 31998
7Antibodies, MonoclonalPhase 34039
8Atorvastatin CalciumPhase 3760134523-03-8
9
Captoprilapproved3462571-86-244093
Synonyms:
(2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline
(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline
1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S)
1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline
1j37
3-Mercapto-2-methylpropionyl-proline
62571-86-2
AC-12047
AC1L2B4L
AC1Q29GZ
AC1Q5R48
Acediur
Aceplus
Acepress
Acepril
Alopresin
Apopril
Apopril (TN)
Asisten
BB_NC-2104
BIM-0050290.0001
BPBio1_000063
BRD-K54529596-001-04-0
BSPBio_000057
BSPBio_002976
C 4042
C4042_SIAL
C4042_SIGMA
C8856_SIAL
C9H15NO3S
CHEBI:3380
CHEMBL1560
CHEMBL82
CID44093
CP
CPD0-2067
CPD000059061
Capoten
Capoten (TN)
Captolane
Captopril (JP15/USP/INN)
Captopril [USAN:INN:BAN:JAN]
Captoprilum
Captoprilum [INN-Latin]
Captopryl
Captoril
Captril
Cesplon
D-2-Methyl-3-mercaptopropanoyl-L-proline
D-3-Mercapto-2-methylpropanoyl-L-proline
D-3-Mercapto-2-methylpropionylproline
D00251
DB01197
Dilabar
DivK1c_000208
EINECS 263-607-1
EU-0100302
FT-0082749
Garranil
Garranil (discontinued)
HMS1921C12
HMS2089P19
 
HMS2092I12
HMS500K10
HSDB 6527
Hipertil
Hypertil
IDI1_000208
Isopresol
KBio1_000208
KBio2_001168
KBio2_003736
KBio2_006304
KBio3_002196
KBioGR_001321
KBioSS_001168
L-Captopril
LS-137465
Lopac-C-4042
Lopac0_000302
Lopirin
Lopirin [Switzerland]
Lopril
MCO
MLS000069484
MLS001076488
MolPort-001-794-639
N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline
NCGC00015235-01
NCGC00015235-02
NCGC00023654-03
NCGC00023654-04
NCGC00023654-05
NCGC00023654-06
NCGC00023654-07
NCGC00023654-08
NCGC00023654-09
NCGC00023654-10
NINDS_000208
Prestwick3_000019
Prestwick_103
SA 333
SAM002564201
SMP1_000056
SMR000059061
SPBio_001022
SPECTRUM1500682
SQ 14,225
SQ 14225
SQ-14,225
SQ-14,534
SQ-14225
SQ-14534
ST079562
STK802012
Spectrum2_001211
Spectrum3_001388
Spectrum4_000811
Spectrum5_001587
Spectrum_000688
Tenosbon
Tensiomin
Tensobon
Tensoprel
UNII-9G64RSX1XD
UPCMLD-DP003
UPCMLD-DP003:001
X8Z
[2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline
captopril
10glucocorticoids5103

Interventional clinical trials:

idNameStatusNCT IDPhase
1Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying TherapyCompletedNCT01623115Phase 3
2Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism HypertensionCompletedNCT00005394
3Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable AldosteronismCompletedNCT00004354
4Primary Aldosteronism In Hypertensive Patients in ChinaRecruitingNCT03155139

Search NIH Clinical Center for Aldosteronism, Glucocorticoid-Remediable


Cochrane evidence based reviews: glucocorticoid-remediable aldosteronism

Genetic Tests for Aldosteronism, Glucocorticoid-Remediable

About this section

Genetic tests related to Aldosteronism, Glucocorticoid-Remediable:

id Genetic test Affiliating Genes
1 Hyperaldosteronism, Familial, Type I27
2 Glucocorticoid-Remediable Aldosteronism24 CYP11B2

Anatomical Context for Aldosteronism, Glucocorticoid-Remediable

About this section

MalaCards organs/tissues related to Aldosteronism, Glucocorticoid-Remediable:

36
Adrenal gland

Publications for Aldosteronism, Glucocorticoid-Remediable

About this section

Variations for Aldosteronism, Glucocorticoid-Remediable

About this section

Clinvar genetic disease variations for Aldosteronism, Glucocorticoid-Remediable:

5
id Gene Variation Type Significance SNP ID Assembly Location
1CYP11B1CYP11B1, CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERAundetermined variantPathogenic

Expression for genes affiliated with Aldosteronism, Glucocorticoid-Remediable

About this section
Search GEO for disease gene expression data for Aldosteronism, Glucocorticoid-Remediable.

Pathways for genes affiliated with Aldosteronism, Glucocorticoid-Remediable

About this section

GO Terms for genes affiliated with Aldosteronism, Glucocorticoid-Remediable

About this section

Biological processes related to Aldosteronism, Glucocorticoid-Remediable according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1aldosterone biosynthetic processGO:003234210.4CYP11B1, CYP11B2
2C21-steroid hormone biosynthetic processGO:000670010.4CYP11B1, CYP11B2
3cellular response to hormone stimulusGO:003287010.4CYP11B1, CYP11B2
4cellular response to potassium ionGO:003586510.4CYP11B1, CYP11B2
5cortisol biosynthetic processGO:003465110.4CYP11B1, CYP11B2
6steroid biosynthetic processGO:000669410.3CYP11B1, CYP11B2
7angiotensin maturationGO:000200310.2AGT, REN
8regulation of blood volume by renin-angiotensinGO:000201610.1AGT, REN
9renin-angiotensin regulation of aldosterone productionGO:000201810.1AGT, REN
10glucocorticoid biosynthetic processGO:00067049.9CYP11B1, HSD11B2
11regulation of blood volume by renal aldosteroneGO:00020179.8CYP11B2, HSD11B2
12steroid hormone mediated signaling pathwayGO:00434019.8NR3C1, NR3C2
13sterol metabolic processGO:00161259.8CYP11B1, CYP11B2
14regulation of blood pressureGO:00082179.2AGT, CYP11B1, POMC, REN

Molecular functions related to Aldosteronism, Glucocorticoid-Remediable according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1corticosterone 18-monooxygenase activityGO:004778310.3CYP11B1, CYP11B2
2steroid 11-beta-monooxygenase activityGO:000450710.3CYP11B1, CYP11B2
3steroid hormone receptor activityGO:00037079.4NR3C1, NR3C2
4steroid bindingGO:00054969.0HSD11B2, NR3C1, NR3C2

Sources for Aldosteronism, Glucocorticoid-Remediable

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet